The Department of Health and Human Services recently cut $500 million in mRNA research funding. “mRNA technology poses more risks than benefits,” HHS Secretary Robert F. Kennedy Jr. said in a statement, claiming that the department’s experts had “reviewed the science, listened to the experts, and acted.”

This is just the latest blow in the agency’s misguided efforts to wind down mRNA vaccine development. In May, HSS terminated Moderna’s contract for an mRNA-based bird flu vaccine that was awarded in 2024 by former President Joe Biden’s administration. The reason? HHS deemed that “continued investment” was not “justifiable.”

That’s an absurd conclusion. Earlier this year, Moderna announced that its experimental vaccine for bird flu — a disease that has already sickened dozens of Americans

See Full Page